Banco Santander enters May with a quiet but notable story unfolding in its lending market: the cost to borrow the stock has more than doubled in the past month, even as short interest itself remains negligible. That disconnect — tighter borrow conditions without a meaningful short position — is the week's most interesting tension.
The borrow cost story is the one thing that moves the needle here. Cost to borrow has climbed to 1.36% annualised from 0.66% a month ago, a 107% rise over 30 days. The move accelerated sharply this week, with the rate jumping 45% in five sessions alone. Yet short interest is barely registering — combined estimates put SI at under 1% of the free float, and the ORTEX short score of 33 places SAN well into the low-conviction range. Availability in the lending pool remains ample, meaning the borrow squeeze reflects demand for hedges rather than a crowded short. The lending market is tighter than it was, but there's no structural pressure building.
The Q1 earnings print, released on April 29, tells a more constructive story. Net interest income reached €11.1 billion, up from €10.7 billion a year ago. Net income jumped to €5.5 billion, a 60% increase on the €3.4 billion recorded in Q1 2025. Basic EPS came in at €0.36, compared to €0.21 a year ago. The stock barely reacted — up just 0.13% on the day — suggesting the market had already priced in the strength. The EPS surprise factor score ranks in the 93rd percentile of the universe, underlining that Santander has a strong track record of beating expectations.
Valuation remains undemanding by European banking standards. The P/E ratio runs at 9.4x, with the price-to-book at 1.3x. Both multiples have ticked up modestly over the past month, consistent with a stock that has gained 3.6% over 30 days before pulling back 1.9% on the week to close at €10.17. The analyst consensus price target of €12.02 implies roughly 18% upside from current levels, a gap that has attracted persistent institutional accumulation. BlackRock holds just over 7% of shares. Vanguard, Dodge & Cox, and Fidelity have all added to positions in the most recent reporting periods, reinforcing the sense that large passive and active allocators see the valuation case as intact.
The most distinctive data point from recent insider activity is executive chairwoman Ana Botín's open-market purchases in early March. She bought 300,000 shares across three transactions — paying between €9.48 and €9.79 per share — a total outlay of roughly $3.4 million. That buying came as the stock traded roughly 7% below current levels. No insider has sold since. The net 90-day insider position sits firmly positive, with awards and purchases outweighing a single executive disposal in early March.
The news flow adds another layer this week. Bloomberg reported that Santander has been pitching buy-now-pay-later loan risk to institutional investors — a sign the bank is actively managing its consumer credit exposure and exploring capital-light distribution. Separately, reports continue to circulate about the potential disappearance of the TSB brand from UK high streets as the Santander takeover integration advances. Neither headline is a near-term catalyst, but both point to a management team actively reshaping the balance sheet and the franchise.
The next scheduled earnings date is July 22. Between now and then, what to watch is whether the borrow cost continues to drift higher — and whether that signals genuine hedging demand building ahead of the Q2 print, or simply a temporary tightening in a market with very few active short sellers.
See the live data behind this article on ORTEX.
Open SAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
